Literature DB >> 11549828

H. pylori infection and visceral hypersensitivity in patients with irritable bowel syndrome.

C Gerards1, A Leodolter, B Glasbrenner, P Malfertheiner.   

Abstract

BACKGROUND/AIM: Irritable bowel syndrome (IBS) is characterized by abdominal pain and changes in stool habits. Visceral hypersensitivity (VH) is a key factor in the pathophysiology of IBS. The role of Helicobacter pylori infection in the induction of VH in the upper gastrointestinal tract is controversially discussed. The aim of this study is to evaluate the value of rectal barostat in eliciting abdominal symptoms in patients with IBS in relation to H. pylori infection. PATIENTS AND METHODS: 31 patients (19 female, 12 male, mean age 45.6 +/- 10 years) with normal colonoscopy and clinical signs of IBS were examined by rectal barostat (pressure-controlled balloon distension in the rectum). Induction of typical abdominal discomfort (far from the balloon) defined the examination positive. Level of nonpainful perception (L1), feeling of defecation (L2), and pain or stool urgency (L3) were registered in comparison with a healthy control group (CG; n = 15, 9 female, 6 male). The H. pylori status was defined by (13)C-urea breath test (n = 46).
RESULTS: Typical abdominal discomfort was induced in 9 patients (pain group, PG) by pressure-controlled rectal distension (H. pylori status: 8 positive, 1 negative). Patients not presenting with abdominal pain to rectal distension (nonpain group, NPG) were all H. pylori negative (p < 0.001). L3 as an indicator of VH was reached at a lower pressure threshold in PG than in NPG or CG (p < 0.05). The perception was not different between NPG and CG (p > 0.05).
CONCLUSIONS: The induction of typical abdominal discomfort in patients with IBS by the use of rectal barostat occurred predominantly in H. pylori infected patients and suggests that H. pylori infection may be involved in triggering VH in patients with IBS. Further studies in larger patient groups and after H. pylori eradication therapy are needed to confirm and extend this observation. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11549828     DOI: 10.1159/000050673

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  10 in total

1.  Blastocystis subtypes isolated from irritable bowel syndrome patients and co-infection with Helicobacter pylori.

Authors:  Ayman A El-Badry; Wegdan M Abd El Wahab; Doaa A Hamdy; Alaa Aboud
Journal:  Parasitol Res       Date:  2017-11-14       Impact factor: 2.289

Review 2.  Brain-gut axis in the pathogenesis of Helicobacter pylori infection.

Authors:  Jacek Budzyński; Maria Kłopocka
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

3.  Effect of Helicobacter pylori infection on the link between GLP-1 expression and motility of the gastrointestinal tract.

Authors:  Hirotsugu Eda; Hirokazu Fukui; Ryosuke Uchiyama; Yoshitaka Kitayama; Ken Hara; Mo Yang; Mio Kodani; Toshihiko Tomita; Tadayuki Oshima; Jiro Watari; Hiroko Tsutsui; Hiroto Miwa
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

4.  Is there an association between Helicobacter pylori infection and irritable bowel syndrome? A meta-analysis.

Authors:  Qin Xiang Ng; Nadine Xinhui Foo; Wayren Loke; Yun Qing Koh; Vanessa Jing Min Seah; Alex Yu Sen Soh; Wee Song Yeo
Journal:  World J Gastroenterol       Date:  2019-10-07       Impact factor: 5.742

5.  The Association between Helicobacter pylori Infection and Irritable Bowel Syndrome: A Meta-Analysis.

Authors:  Yun-A Kim; Yoon Jeong Cho; Sang Gyu Kwak
Journal:  Int J Environ Res Public Health       Date:  2020-04-07       Impact factor: 3.390

6.  A questionnaire-based survey on the etiopathogenesis of chronic constipation during a medical check-up in Japan.

Authors:  Koji Otani; Toshio Watanabe; Kanae Takahashi; Masaki Ominami; Yuji Nadatani; Shusei Fukunaga; Shuhei Hosomi; Noriko Kamata; Fumio Tanaka; Yasuaki Nagami; Koichi Taira; Tatsuo Kimura; Shinya Fukumoto; Yasuhiro Fujiwara
Journal:  J Clin Biochem Nutr       Date:  2022-01-19       Impact factor: 3.114

Review 7.  Helicobacterpylori Infection-A Risk Factor for Irritable Bowel Syndrome? An Updated Systematic Review and Meta-Analysis.

Authors:  Ziyan Wang; Yuhua Liu; Yinglong Peng; Liang Peng
Journal:  Medicina (Kaunas)       Date:  2022-08-02       Impact factor: 2.948

8.  Irritable bowel syndrome is associated with gastroesophageal reflux symptom but not erosive esophagitis.

Authors:  Su Youn Nam; Kum Hei Ryu; Bum Joon Park
Journal:  J Neurogastroenterol Motil       Date:  2013-10-07       Impact factor: 4.924

9.  Risk for Irritable Bowel Syndrome in Patients with Helicobacter Pylori Infection: A Nationwide Population-Based Study Cohort Study in Taiwan.

Authors:  Chia-Ming Liang; Chih-Hsiung Hsu; Chi-Hsiang Chung; Chao-Yang Chen; Lin-Yin Wang; Sheng-Der Hsu; Pi-Kai Chang; Zhi-Jie Hong; Wu-Chien Chien; Je-Ming Hu
Journal:  Int J Environ Res Public Health       Date:  2020-05-25       Impact factor: 3.390

Review 10.  Potential prebiotics and their transmission mechanisms: Recent approaches.

Authors:  Ishu Khangwal; Pratyoosh Shukla
Journal:  J Food Drug Anal       Date:  2019-03-04       Impact factor: 6.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.